Overexpression of PPARG was found to enhance the proliferation of HER2-positive breast cancer cells (Figure 3C), while inhibition of PPARG resulted in inhibition of HER2-positive breast cancer cell proliferation (Supplementary figure 2C). Here, ERBB2 is linked to breast cancer.